Centre should enact law to check cow slaughter: Sadhvi Saraswati

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Yadgir, Feb 27: A four-year-old girl and her four-month-old sibling died after consuming pesticide mistaking it to juice at Kodal village in Vadagera taluk of Yadgir district on Wednesday.

After noticing her daughters lying lifeless, mother Shehnaz attempted suicide by consuming poison.

Khairunna (4) mistook pesticide for juice and consumed it while her mother was busy doing household chores. She also reportedly made her four-month-old sister drink. 

Upon seeing the siblings lying lifeless, Shehnaz, fearing her husband and mother-in-law, attempted suicide by consuming poison.

All three were rushed to Yadgir district hospital. The siblings died while their mother is battling for her life.

Feb 3: Shine Shetty, who was last seen essaying the character of 'Chandu' in the popular daily soap 'Lakshmi Baramma', made a grand comeback to the small screen with Bigg Boss Kannada season 7 as one of the contestants. The actor went emotional after his name was announced by Sudeep as the winner. He thanked the host, his family and friends and the viewers as well for continuous support.

During his stay in the house, the actor had the privilege to become the captain of the house twice. He is also the only candidate who has earned 'Kicchana Chappale' (applaud of appraisal) the maximum number of times.

Shine has been in the headlines for his equation with other housemates. His growing friendship with Deepika Das has been creating a lot of buzz ever since the launch of the show. Shine has always shown interest in Deepika. He has always admired Deepika and was seen complimenting her style statements.

Shine Shetty's journey inside the Bigg Boss house is worth a mention. From showcasing his talents to giving his best shot in the tasks and activities, the actor was always on the forefront.

His friendly nature and care of his inmates can also never be missed.

Bigg Boss Kannada 7 kick-started on October 13th 2019 with Kiccha Sudeepa continued to host the show. The show, which returned to the small screen with 'only-celeb' format consisted of 18 primary contestants, who entered the house during the grand premiere of the season.

Within a short span, two wild card entrants made a surprise entry into the house. The show was surely a roller coaster ride with unexpected twists and entertained the viewers to the fullest.